ALAN C. MENDELSON - 21 May 2021 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Alan C. Mendelson
Issuer symbol
CHRS
Transactions as of
21 May 2021
Net transactions value
$0
Form type
4
Filing time
25 May 2021, 16:51:40 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 21 May 2021 Common Stock 20,000 $13.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 21, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.